Current κ Opioid Receptor Ligands and Discovery of a New Molecular Scaffold as a κ Opioid Receptor Antagonist Using Pharmacophore-Based Virtual Screening

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|42|7362-7372

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.42, 2013-12, pp. : 7362-7372

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of κ-opioid receptor ligands on intracranial self-stimulation in rats

By Todtenkopf Mark   Marcus Jacqueline   Portoghese Philip   Carlezon William  

Psychopharmacology, Vol. 172, Iss. 4, 2004-04 ,pp. : 463-470

Springer Publishing Company

Access to resources Recommend Favorite

Essential Structure of the κ Opioid Receptor Agonist Nalfurafine for Binding to the κ Receptor

By  

Current Pharmaceutical Design, Vol. 19, Iss. 42, 2013-12 ,pp. : 7400-7414

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacophore-Based Virtual Screening

By  

Current Medicinal Chemistry, Vol. 15, Iss. 10, 2008-04 ,pp. : 1018-1024

Bentham Science Publishers

Access to resources Recommend Favorite

Kappa-opioid receptor ligands

By Husbands Stephen M  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 12, 2004-12 ,pp. : 1725-1741

Informa Healthcare

Access to resources Recommend Favorite

Effect of the tyramine fragment of opioid receptor ligands on their agonist and antagonist properties

By Kuz’mina N.   Osipova E.   Kuz’min V.   Sitnikov V.  

Pharmaceutical Chemistry Journal, Vol. 40, Iss. 5, 2006-05 ,pp. : 254-260

Springer Publishing Company

Access to resources Recommend Favorite